Albemarle (ALB) Investor presentation summary

Strategic positioning and business overview

• Recognized as a global leader in transforming essential resources for mobility, energy, connectivity, and health, with a focus on operational excellence and resilience.

• Operates in over 70 countries with more than 7,800 employees, $16B in assets, and over 1,500 active patents.

• Maintains a diversified portfolio across specialties and energy storage, leveraging world-class resources and process chemistry expertise.

• Core values emphasize care, humility, curiosity, accountability, collaboration, and integrity.

Financial performance and outlook

• FY 2025 net sales reached $5.1B with an adjusted EBITDA margin of 21%; 2026 outlook ranges from $4.1B to $7.8B in net sales depending on lithium prices.

• Adjusted EBITDA for 2026 projected between $0.9B and $4.4B, with margins from low-20% to mid-50% based on market scenarios.

• Specialties segment FY 2026 net sales expected at $1.4B–$1.6B, with adjusted EBITDA of $275M–$325M.

• Energy Storage segment FY 2026 net sales projected at $2.5B–$6.1B, with adjusted EBITDA of $0.7B–$4.1B, depending on lithium market prices.

Operational efficiency and capital allocation

• Achieved ~$100M in cost and productivity improvements YTD, targeting $100–$150M for the year.

• Focused CapEx discipline, reducing capital intensity and prioritizing high-return, quick payback projects.

• Recent deleveraging actions reduced net debt to EBITDA ratio to 0.5x and lowered annual interest expense by ~$60M.

• Operating cash flow conversion trending toward long-term target of 60–70%.